Early menopause can go undiagnosed for years. A new WHO feature highlights the need for better research, timely diagnosis and informed care for women.
At 26, Priya Satalkar-Götz experienced a hot flush while returning from a work trip to India. The sudden wave of heat was so intense it alarmed her. As a physician, she recognised what it might mean. Yet she struggled to accept the possibility that she could be experiencing menopause so young.
Over the following years, the symptoms became harder to ignore. Her menstrual cycles grew increasingly irregular. Night-time hot flushes disrupted her sleep. But when she sought medical advice, her symptoms were attributed to stress, lifestyle changes or weight loss.
It took years of consultations before blood tests finally confirmed the diagnosis. At 33, she learnt that she was already at an advanced stage of menopause.
Satalkar-Götz, a physician and scientist who works with the United Nations’ Special Programme of Research, Development and Research Training in Human Reproduction, shared her experience in a World Health Organization feature published on October 16, 2026.
Her account reveals a troubling gap in women’s healthcare: recognising menopause can be difficult even for someone trained in medicine. For women who have limited access to specialists, reliable health information or the confidence to question a diagnosis, the journey may be even more complicated.
What happens when a condition commonly associated with middle age begins decades earlier—and the symptoms are mistaken for something else?
When menopause arrives before women expect it
Menopause is a natural biological transition, but its timing matters.
According to the WHO, most women experience natural menopause between the ages of 45 and 55. Menopause before the age of 40 is generally classified as premature menopause, while early menopause usually refers to menopause between 40 and 44.
Premature ovarian insufficiency (POI), a related but distinct condition, occurs when ovarian function declines before the age of 40. It can cause irregular or absent periods, reduced fertility and symptoms associated with lower oestrogen levels. Unlike established menopause, ovarian activity in POI can sometimes fluctuate or resume.
These distinctions matter because a woman experiencing irregular periods in her twenties or thirties may not immediately associate them with a menopausal condition.
Hot flushes and night sweats are among the recognised symptoms. Others include sleep disturbances, mood changes, vaginal dryness and difficulties with sexual wellbeing. Some women experience several symptoms, while others have relatively few.
The absence of dramatic symptoms does not necessarily mean that the underlying condition has no long-term consequences.
A diagnosis of premature ovarian insufficiency can have implications beyond fertility. Prolonged low oestrogen levels are associated with bone loss and increased cardiovascular risks, making timely assessment and appropriate care important.
Yet these conditions can be difficult to recognise when healthcare providers and patients do not initially expect menopause-related symptoms at a young age.
The research gap behind the diagnosis
Satalkar-Götz’s experience was particularly striking because she had the medical knowledge to recognise the possibility of early menopause. Even so, she faced uncertainty about the available evidence and treatment options.
When she reviewed the scientific literature between 2012 and 2015, she found limited research directly addressing the needs of women experiencing menopause at younger ages.
Much of the existing research focused on women reaching menopause around the usual age. This left important questions about early menopause unanswered, including which interventions work best for younger women and what their long-term effects might be.
The consequences are not limited to uncertainty in the consulting room. When evidence is incomplete, clinicians may follow different approaches, leaving patients with inconsistent advice about treatment, fertility and future health risks.
The WHO’s October 16 feature calls for stronger long-term research and evidence-based global guidance. Such guidance could help healthcare professionals make more consistent decisions while identifying where the evidence remains limited.
For women, better research could mean earlier recognition, clearer explanations and more informed choices about treatment.
A study of more than 716,000 women raises further questions
The scale of the issue becomes clearer when viewed alongside a study published in BMJ Global Health on July 7, 2026.
Researchers pooled data from 716,648 women aged 30–49 across 44 low- and middle-income countries, using the most recent available Demographic and Health Surveys conducted since 2015.
The study estimated that 7.1% of women in the combined study population had experienced premature or early menopause. This is roughly one in 14 women.
The researchers also found considerable differences between countries, with estimates ranging from 2.3% in Jordan to 12% in Ethiopia.
The study identified associations between menopause and several social and demographic factors. Rural residence was associated with higher odds of premature or early menopause, while higher education, employment and later marriage and first childbirth were associated with lower odds.
These findings do not establish that any one social factor causes early menopause. Nor does the pooled estimate establish the prevalence in India. The study does, however, highlight the need to examine how health, education and access to services intersect with women’s experiences of reproductive ageing.
For India, an important next step is to establish what national and state-level evidence can tell us about the condition, whether women are receiving timely diagnoses and where gaps in care persist.
What does this mean for women in India?
For a woman in her twenties or thirties, irregular periods may raise several possibilities. Stress, changes in weight, thyroid disorders, pregnancy, polycystic ovary syndrome and other conditions can affect menstrual cycles.
Menstrual changes alone cannot establish a diagnosis of early menopause or premature ovarian insufficiency. This is precisely why clinical assessment matters.
When symptoms persist, periods become markedly irregular or stop, or other menopause-associated symptoms develop unexpectedly, women should be encouraged to seek medical evaluation rather than assume that the problem is temporary.
A healthcare professional may assess menstrual and medical history, medication use, family history and relevant symptoms before deciding which investigations are appropriate.
The diagnosis of premature ovarian insufficiency is based on clinical assessment and hormonal testing. Current international guidance recommends considering the condition in women under 40 who have experienced menstrual disturbance for at least four months. An elevated follicle-stimulating hormone level can support the diagnosis; repeat testing may be needed when uncertainty remains.
These are clinical decisions, not tests that women should attempt to interpret on their own.
For women who receive a diagnosis, care should extend beyond whether they can conceive. Discussions may include hormone treatment where appropriate, bone health, cardiovascular risk, fertility preferences, sexual wellbeing and emotional support.
Treatment must be individualised. Hormone therapy is not suitable for everyone, and decisions should take account of medical history, contraindications and personal preferences.
India’s 2026 clinical practice recommendations from the Indian Menopause Society address premature ovarian insufficiency and early menopause, including the importance of timely diagnosis and appropriate management. The challenge is to understand how consistently such recommendations translate into accessible care across different settings.
Fertility is only one part of the story
An early menopause diagnosis can change how a woman thinks about her future.
For women who hope to have children, the possibility of reduced fertility can be deeply distressing. Some may need specialist advice about reproductive options, while others may already have decided not to have children.
But fertility should not become the only measure through which a diagnosis is understood.
In her WHO account, Satalkar-Götz described the emotional impact of learning about her condition. Even though she understood the medical implications, she felt overwhelmed and needed time to process the news.
Support from her partner, friends and family helped her navigate that experience. She also described the importance of finding a specialist who listened to her concerns and involved her in decisions about treatment.
Her account illustrates a dimension of healthcare that statistics cannot fully capture: receiving a diagnosis is not the same as being supported through it.
Women may need clear explanations, opportunities to discuss fertility and treatment, and space to acknowledge the emotional consequences of an unexpected change in their health.
Healthcare professionals can play an important role by communicating diagnoses sensitively and avoiding assumptions about a woman’s reproductive plans or personal priorities.
Why better menopause care matters beyond the clinic
The effects of early menopause can extend into everyday life.
Persistent night sweats and sleep disruption may affect concentration and energy. Other symptoms can affect sexual wellbeing, relationships and emotional health. Women may also have to manage repeated appointments while balancing employment and family responsibilities.
Workplaces can help by allowing reasonable flexibility for medical appointments and providing supportive arrangements when symptoms affect daily functioning.
Health systems also need to consider whether women can access appropriate specialists, diagnostic services and follow-up care without facing unnecessary financial or geographical barriers.
For women in rural areas, the availability of specialist services may be particularly important to investigate. But the scale of that gap in India needs to be established through local data and reporting rather than assumed.
The same applies to awareness. It is not enough to say that menopause is a taboo subject. Reporting needs to establish what women know, what healthcare providers tell them, how much diagnosis and treatment cost, and where the system fails to respond.
These are questions that can be answered through interviews with patients, gynaecologists, endocrinologists and public-health researchers.
From awareness to answers
The WHO’s latest feature makes a case for better research and more consistent global guidance. The challenge for health systems is to turn that evidence into practical care.
For India, several questions deserve closer examination. How often are younger women presenting with symptoms associated with premature ovarian insufficiency? How long does diagnosis take? Do women have access to clinicians trained to recognise the condition? Are they counselled about long-term health, fertility and treatment options after diagnosis?
Reliable national or state-level data on these questions would help establish where interventions are most urgently needed.
Until then, women should not be expected to diagnose themselves, and persistent symptoms should not be dismissed simply because someone appears too young to experience menopause.
Satalkar-Götz’s experience offers a powerful reminder that medical knowledge alone does not protect women from uncertainty. She needed a clinician who listened, a diagnosis supported by testing and treatment decisions informed by evidence.
No woman should have to spend years searching for an explanation for symptoms that deserve proper investigation.
Early menopause may not always be preventable, and not every unanswered question has an immediate medical solution. But better research, timely diagnosis, compassionate care and honest conversations can make the experience less isolating—and help women make informed decisions about their health and their future.
